Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
bioinformatics analysis
biomarkers
ceRNA
diabetic neuropathy
mechanisms
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
05
2022
accepted:
20
06
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
3
8
2022
Statut:
epublish
Résumé
Diabetic nephropathy (DN) is one of the common chronic complications of diabetes with unclear molecular mechanisms, which is associated with end-stage renal disease (ESRD) and chronic kidney disease (CKD). Our study intended to construct a competing endogenous RNA (ceRNA) network
Identifiants
pubmed: 35909518
doi: 10.3389/fendo.2022.934022
pmc: PMC9329782
doi:
Substances chimiques
Biomarkers
0
MIRN-944 microRNA, human
0
MIRN326 microRNA, human
0
MIRN577 microRNA, human
0
MicroRNAs
0
RNA, Long Noncoding
0
RNA, Messenger
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
934022Informations de copyright
Copyright © 2022 Guo, Dai, Jiang and Gao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Genet Mol Res. 2015 Dec 01;14(4):15462-70
pubmed: 26634512
Korean J Intern Med. 2019 May;34(3):480-491
pubmed: 31048658
Diabetes Metab Syndr Obes. 2021 Feb 17;14:729-740
pubmed: 33628038
Genes Genomics. 2019 Apr;41(4):389-395
pubmed: 30506122
Nat Biotechnol. 2021 Nov;39(11):1453-1465
pubmed: 34140680
J Biochem. 2021 Jul 3;169(5):575-583
pubmed: 33479745
J Neuroimmunol. 2016 Aug 15;297:92-7
pubmed: 27397081
J Clin Pathol. 2021 Sep;74(9):548-552
pubmed: 34039664
Med Microbiol Immunol. 2020 Aug;209(4):545-552
pubmed: 32440787
Gene. 2021 Jan 10;765:145076
pubmed: 32860899
Mol Biol Rep. 2021 Dec;48(12):7719-7732
pubmed: 34689283
J Ovarian Res. 2020 Oct 17;13(1):122
pubmed: 33069244
Sci Rep. 2021 Jan 14;11(1):1331
pubmed: 33446695
Onco Targets Ther. 2021 Mar 31;14:2311-2325
pubmed: 33833529
Cancer Manag Res. 2021 Aug 04;13:6079-6088
pubmed: 34377026
Adipocyte. 2022 Dec;11(1):190-201
pubmed: 35412419
Front Genet. 2021 Nov 01;12:767654
pubmed: 34790229
Clin Dev Immunol. 2011;2011:374859
pubmed: 21647406
Cancer Commun (Lond). 2021 Jun;41(6):472-491
pubmed: 33638620
Pharmacol Res. 2021 Aug;170:105520
pubmed: 33639232
Transl Vis Sci Technol. 2021 Apr 1;10(4):20
pubmed: 34003998
Front Cell Dev Biol. 2021 Jan 25;8:618536
pubmed: 33569382
Int J Oncol. 2017 Jan;50(1):263-271
pubmed: 27922670
Biosci Rep. 2021 Jun 25;41(6):
pubmed: 33634308
BMC Nephrol. 2021 Jan 12;22(1):27
pubmed: 33435900
Front Endocrinol (Lausanne). 2022 Mar 15;13:818388
pubmed: 35370964
Diabetes. 2022 Apr 1;71(4):853-861
pubmed: 35073575
PeerJ. 2020 Jan 17;8:e8390
pubmed: 31988808
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E34-E42
pubmed: 32228319
Diabetes Res Clin Pract. 2021 Dec;182:109122
pubmed: 34742785
Ann Transl Med. 2021 Sep;9(18):1419
pubmed: 34733971
Methods Mol Biol. 2016;1418:93-110
pubmed: 27008011
Gene. 2021 May 15;780:145532
pubmed: 33631244
Clin Sci (Lond). 2020 Dec 11;134(23):3175-3193
pubmed: 33241846
Rep Biochem Mol Biol. 2021 Jul;10(2):243-256
pubmed: 34604414
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Int Immunopharmacol. 2018 Feb;55:9-19
pubmed: 29207360
iScience. 2020 May 22;23(5):101104
pubmed: 32428859
Biomed Res Int. 2021 Jul 8;2021:1497449
pubmed: 34307650
Front Pharmacol. 2020 Jul 31;11:881
pubmed: 32903837
Nephrol Dial Transplant. 2018 Feb 1;33(2):248-256
pubmed: 28339909
Evid Based Complement Alternat Med. 2019 Mar 07;2019:3513179
pubmed: 30984273
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331